Taken together, the experimental data gathered in the last two decades strongly support the notion of T2 ribonucleases (and particularly human RNASET2) acting as highly pleiotropic tumor suppressor proteins, endowed with the ability to hamper tumor growth in a broad spectrum of human cancer types by many independent mechanisms. The gene discussed is RNASET2; the disease is neoplasm.